Related Experiment Video
Updated: May 13, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation
Lalitha Nayak1, Lediana Goduni, Yoichi Takami
1Case Cardiovascular Research Institute, Department of Medicine, Harrington Heart and Vascular Institute, Cleveland, Ohio; Division of Hematology and Oncology, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio.
Abstract:
Although myeloid cell activation is requisite for an optimal innate immune response, this process must be tightly controlled to prevent collateral host tissue damage. Kruppel-like factor 2 (KLF2) is a potent regulator of myeloid cell proinflammatory activation. As an approximately 30% to 50% reduction in KLF2 levels has been observed in human subjects with acute or chronic inflammatory disorders, we studied the biological response to inflammation in KLF2(+/-) mice. Herein, we show that partial deficiency of KLF2 modulates the in vivo response to acute (sepsis) and subacute (skin) inflammatory challenge. Mechanistically, we link the anti-inflammatory effects of KLF2 to the inhibition of NF-κB transcriptional activity. Collectively, the observations provide biologically relevant insights into KLF2-mediated modulation of these inflammatory processes that could potentially be manipulated for therapeutic gain.
Related Concept Videos
Master Transcription Regulators
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Chronic Inflammation: Introduction
General Transcription Factors
Inflammatory Bowel Disease II: Ulcerative Colitis
Acute Inflammation II: Local and Systemic Effects

